Potent cyclic urea HIV protease inhibitors with benzofused heterocycles as P2/P2′ groups
- 1 December 1996
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 6 (24) , 2919-2924
- https://doi.org/10.1016/s0960-894x(96)00531-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 InfectionNew England Journal of Medicine, 1995
- A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 ProteaseNew England Journal of Medicine, 1995
- Toward Improved Anti-HIV Chemotherapy: Therapeutic Strategies for Intervention with HIV InfectionsJournal of Medicinal Chemistry, 1995
- Safety and activity of saquinavir in HIV infectionThe Lancet, 1995
- Targeting HIV-1 protease: A test of drug-design methodologiesTrends in Pharmacological Sciences, 1995
- Chapter 14. HIV Protease InhibitorsPublished by Elsevier ,1994
- STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASEAnnual Review of Biochemistry, 1993
- Recent advances in the design of HIV proteinase inhibitorsAntiviral Research, 1992
- Inhibitors of HIV-1 ProteaseJournal of Enzyme Inhibition, 1992
- HIV protease: a novel chemotherapeutic target for AIDSJournal of Medicinal Chemistry, 1991